Literature DB >> 25070233

Chondrosarcoma of bone.

Lee R Leddy1, Robert E Holmes.   

Abstract

Chondrosarcoma is a cartilage forming neoplasm, which is the second most common primary malignancy of bone. Clinicians who treat chondrosarcoma patients must determine the grade of the tumor, and must ascertain the likelihood of metastasis. Acral lesions are unlikely to metastasize, regardless of grade, whereas axial, or more proximal lesions are much more likely to metastasize than tumors found in the distal extremities with equivalent histology. Chondrosarcoma is resistant to both chemotherapy and radiation, making wide local excision the only treatment. Local recurrence is frequently seen after intralesional excision, thus wide local excision is sometimes employed despite significant morbidity, even in low-grade lesions. Chondrosarcoma is difficult to treat. The surgeon must balance the risk of significant morbidity with the ability to minimize the chance of local recurrence and maximize the likelihood of long-term survival.

Entities:  

Mesh:

Year:  2014        PMID: 25070233     DOI: 10.1007/978-3-319-07323-1_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  31 in total

1.  Gab1 regulates SDF-1-induced progression via inhibition of apoptosis pathway induced by PI3K/AKT/Bcl-2/BAX pathway in human chondrosarcoma.

Authors:  Yongqian Fan; Fengjian Yang; Xuhai Cao; Cong Chen; Xuelin Zhang; Xu Zhang; Weilong Lin; Xiaofeng Wang; Chengwei Liang
Journal:  Tumour Biol       Date:  2015-08-16

Review 2.  Pericytes in sarcomas of bone.

Authors:  Le Chang; Vi Nguyen; Alan Nguyen; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-06-16       Impact factor: 3.064

3.  Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.

Authors:  William P Shield; Ashley Cellini; Hongying Tian; Kim Wilson; Yang Dan; Joshua M Abzug; Sonia Garcia; Norifumi Moritani; Ivan Alferiev; Michael Chorny; Masaharu Takigawa; Vincent Y Ng; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  J Orthop Res       Date:  2019-12-19       Impact factor: 3.494

4.  Mice with Trp53 and Rb1 deficiency in chondrocytes spontaneously develop chondrosarcoma via overactivation of YAP signaling.

Authors:  Yang Li; Shuting Yang; Yang Liu; Shuying Yang
Journal:  Cell Death Dis       Date:  2022-06-27       Impact factor: 9.685

5.  Puerarin induces cell apoptosis in human chondrosarcoma cell line SW1353 via inhibition of the PI3K/Akt signaling pathway.

Authors:  Li Huang; Junqing Cao; Lan Cao; Ling Gao; Ying Yang; Li Xu
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

6.  The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2.

Authors:  Dong Jiang; Xiaoming Zheng; Wei Shan; Ying Shan
Journal:  Tumour Biol       Date:  2015-11-23

7.  Proximal humerus chondrosarcoma in a young male patient.

Authors:  Răzvan Ene; Florin Cătălin Cîrstoiu; Mihai Nica; Zsombor Alpár Pánti; Corina Panaitescu; Elisa Popescu; Adrian Vasile Dumitru; Irina Anca Eremia; Adrian Cursaru; Dragoş Ene
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

8.  Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.

Authors:  Chun-Hao Tsai; Hsiao-Chi Tsai; Ho-Ning Huang; Chih-Hung Hung; Chin-Jung Hsu; Yi-Chin Fong; Horng-Chaung Hsu; Yuan-Li Huang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2015-01-01

Review 9.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

10.  Case Report: Reconstruction After Anterior Pubic Hemipelvectomy.

Authors:  Benjamin Murphy; Tharsa Thillainadesan; Kerian Robinson; Anita Clarke; Peter Choong
Journal:  Front Surg       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.